Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Immune Protection by a Cytomegalovirus Vaccine Vector Expressing a Single Low-Avidity Epitope.

Borkner L, Sitnik KM, Dekhtiarenko I, Pulm AK, Tao R, Drexler I, Cicin-Sain L.

J Immunol. 2017 Sep 1;199(5):1737-1747. doi: 10.4049/jimmunol.1602115. Epub 2017 Aug 2.

PMID:
28768725
2.

Peptide Processing Is Critical for T-Cell Memory Inflation and May Be Optimized to Improve Immune Protection by CMV-Based Vaccine Vectors.

Dekhtiarenko I, Ratts RB, Blatnik R, Lee LN, Fischer S, Borkner L, Oduro JD, Marandu TF, Hoppe S, Ruzsics Z, Sonnemann JK, Mansouri M, Meyer C, Lemmermann NA, Holtappels R, Arens R, Klenerman P, Früh K, Reddehase MJ, Riemer AB, Cicin-Sain L.

PLoS Pathog. 2016 Dec 15;12(12):e1006072. doi: 10.1371/journal.ppat.1006072. eCollection 2016 Dec.

3.

The Neonatal CD8+ T Cell Repertoire Rapidly Diversifies during Persistent Viral Infection.

Venturi V, Nzingha K, Amos TG, Charles WC, Dekhtiarenko I, Cicin-Sain L, Davenport MP, Rudd BD.

J Immunol. 2016 Feb 15;196(4):1604-16. doi: 10.4049/jimmunol.1501867. Epub 2016 Jan 13.

4.

Murine cytomegalovirus (CMV) infection via the intranasal route offers a robust model of immunity upon mucosal CMV infection.

Oduro JD, Redeker A, Lemmermann NA, Ebermann L, Marandu TF, Dekhtiarenko I, Holzki JK, Busch DH, Arens R, Čičin-Šain L.

J Gen Virol. 2016 Jan;97(1):185-95. doi: 10.1099/jgv.0.000339. Epub 2015 Nov 10.

PMID:
26555192
5.

Immune Protection against Virus Challenge in Aging Mice Is Not Affected by Latent Herpesviral Infections.

Marandu TF, Oduro JD, Borkner L, Dekhtiarenko I, Uhrlaub JL, Drabig A, Kröger A, Nikolich-Zugich J, Cicin-Sain L.

J Virol. 2015 Nov;89(22):11715-7. doi: 10.1128/JVI.01989-15. Epub 2015 Sep 2.

6.

Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression.

Holzki JK, Dağ F, Dekhtiarenko I, Rand U, Casalegno-Garduño R, Trittel S, May T, Riese P, Čičin-Šain L.

J Virol. 2015 Oct;89(19):9886-95. doi: 10.1128/JVI.01459-15. Epub 2015 Jul 22.

7.

Use of recombinant approaches to construct human cytomegalovirus mutants.

Dekhtiarenko I, Cičin-Šain L, Messerle M.

Methods Mol Biol. 2014;1119:59-79. doi: 10.1007/978-1-62703-788-4_5.

PMID:
24639218
8.

The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens.

Dekhtiarenko I, Jarvis MA, Ruzsics Z, Čičin-Šain L.

J Immunol. 2013 Apr 1;190(7):3399-409. doi: 10.4049/jimmunol.1203173. Epub 2013 Mar 4.

Supplemental Content

Loading ...
Support Center